Global COVID-19 IgM/IgG Rapid Test Kits Competitive Landscape Professional Research Report 2025

Research Summary

COVID-19 IgM/IgG rapid test kits are medical diagnostic tools designed to detect the presence of both immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies specific to the SARS-CoV-2 virus, which causes COVID-19. These kits typically use a small blood sample, obtained through a finger prick or venous draw, and provide results within a short time frame, often within 15 to 20 minutes. IgM antibodies are typically produced by the body in the early stages of infection, while IgG antibodies develop later and can indicate a past infection or potential immunity. The presence of both IgM and IgG antibodies in a person＇s blood can help healthcare professionals assess the stage of infection, identify recent or past exposure to the virus, and provide insights into potential immunity. However, it＇s important to note that these rapid test kits may have varying degrees of accuracy and sensitivity, and they should not be solely relied upon for definitive diagnoses. Confirmatory testing through molecular methods like PCR is necessary to confirm active infections. COVID-19 IgM/IgG rapid test kits play a valuable role in serological studies, surveillance, and screening efforts to understand the spread and impact of the disease in populations.

According to DIResearch's in-depth investigation and research, the global COVID-19 IgM/IgG Rapid Test Kits market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of COVID-19 IgM/IgG Rapid Test Kits include Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech, Epitope Diagnostics, CTK Biotech, Creative Diagnostics, Eagle Biosciences, Sure Biotech, Sugentech, Sensing self, Euroimmun AG, PharmACT, Liming Bio, Livzon Diagnostics, Beijing Wantai, Shenzhen BioEasy Biotechnology, Orient Gene Biotech, INNOVITA, Dynamiker, Guangzhou Wonfo Bio-Tech etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of COVID-19 IgM/IgG Rapid Test Kits. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global COVID-19 IgM/IgG Rapid Test Kits market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the COVID-19 IgM/IgG Rapid Test Kits market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of COVID-19 IgM/IgG Rapid Test Kits industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of COVID-19 IgM/IgG Rapid Test Kits Include:

Cellex

RayBiotech

Biopanda

BioMedomics

GenBody

SD Biosensor

Advaite

Premier Biotech

Epitope Diagnostics

CTK Biotech

Creative Diagnostics

Eagle Biosciences

Sure Biotech

Sugentech

Sensing self

Euroimmun AG

PharmACT

Liming Bio

Livzon Diagnostics

Beijing Wantai

Shenzhen BioEasy Biotechnology

Orient Gene Biotech

INNOVITA

Dynamiker

Guangzhou Wonfo Bio-Tech

COVID-19 IgM/IgG Rapid Test Kits Product Segment Include:

RDT(Rapid Diagnostic Test)

ELISA(Enzyme-linked Immunosorbent Aassay)

Neutralization Assay

COVID-19 IgM/IgG Rapid Test Kits Product Application Include:

Hospital

Special Clinic

Research Institutions

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global COVID-19 IgM/IgG Rapid Test Kits Industry PESTEL Analysis

Chapter 3: Global COVID-19 IgM/IgG Rapid Test Kits Industry Porter’s Five Forces Analysis

Chapter 4: Global COVID-19 IgM/IgG Rapid Test Kits Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global COVID-19 IgM/IgG Rapid Test Kits Market Size and Forecast by Type and Application Analysis

Chapter 6: North America COVID-19 IgM/IgG Rapid Test Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe COVID-19 IgM/IgG Rapid Test Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China COVID-19 IgM/IgG Rapid Test Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) COVID-19 IgM/IgG Rapid Test Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America COVID-19 IgM/IgG Rapid Test Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa COVID-19 IgM/IgG Rapid Test Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global COVID-19 IgM/IgG Rapid Test Kits Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources